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Circadian rhythms are biological processes displaying endogenous and entrainable oscillations of
about 24 h. In mammals the sleep/wake cycle, core body temperature fluctuation, and diurnal
variation of blood pressure and heart rate are among the most well-known circadian rhythms.
These rhythms are not just the consequence of activity/rest cycles, but are also controlled by
molecular clocks, a biological network of fundamental value in the harmonization of physiological
and biochemical processes with the external environment. Substantial evidence suggests that:
1. Dysregulation of the circadian system is a significant risk factor for many health problems such
as metabolic disorders, cardiovascular diseases, impaired immune function, and accelerated
aging. Restoring or strengthening the circadian rhythmmay be therapeutic for these conditions.
2. The incidence and severity of many diseases, such as the onset of cardiovascular events,
chronic obstructive pulmonary disease (COPD), inflammatory diseases, and mental disorders,
are time-dependent.
3. The efficiency and side effects of many drugs has temporal variations.
4. Circadian rhythms can be modulated by some drugs.
Despite the large amount of experimental and epidemiological evidence, the importance of
circadian rhythms has not been paid much attention in real clinical settings. The aim of this
Research Topic in Frontiers is to highlight the therapeutic implications of circadian rhythms.
The mating behavior or close-proximity (CP) displays day/night variation in some insects
including Drosophila melanogaster, which is controlled by molecular clocks and affected by food
consumption. For example, CP rhythm is abolished in per or tim-null flies, and dampened under
low-nutrient conditions. In the research article, Inositols affect the mating circadian rhythm of
Drosophila melanogaster (Sakata et al., 2015), Sakata et al. found that CP rhythm significantly
enhanced by feeding the flies with powdered ice plant, a little-known vegetable that may improve
hyperglycemia in a streptozotocin-induced diabetic rat model. Among various components of ice
plant, myo-inositol could increase the amplitude and shorten the period of CP rhythm. Real-time
reporter assays showed that myo-inositol also shortened the period of the circadian reporter gene
Per2-luc in the mouse cell line NIH3T3. Their data suggested that ice plant and myo-inositol
may be beneficial to insect reproduction, while its potential role in mammals need to be carefully
investigated.
There’s obvious day/night variation in urinary voiding with much more during the day than
at night in human. However, a large portion of human beings suffer excessive urination at night
(nocturia), which dramatically decreases quality of life. Therefore, understanding the underlying
mechanism has significant clinical relevance. Most studies on the circadian rhythm of micturition
were focused on urine production by the kidneys. Although smooth muscle cells from mouse
bladder express a functional and autonomous circadian clock at the molecular level, very few
studies show circadian rhythms in the bladder function. In the research article, Evaluation of
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mouse urinary bladder smooth muscle for diurnal differences
in contractile properties (White et al., 2014), White et al.
measured spontaneous (phasic) and nerve-evoked contractions
of mouse bladder tissue strips collected frommultiple time points
during 24 h and found phasic contraction, but not nerve-evoked
contraction displayed diurnal rhythm.
Circadian rhythm has significant therapeutic implications
in the central nervous system. It has long been known that
circadian disruption by frequent shift work, jet lag, or exposure
to artificial light is a risk factor for several neurodegenerative
diseases, including Alzheimer’s disease. Conversely, many
neurodegenerative diseases result in circadian abnormalities.
Besides, mice lacking clock genes, such as Bmal or Clock/Npas2,
developed marked astrogliosis. In the mini-review, Circadian
clock disruption in neurodegenerative diseases: cause and effect?
(Musiek, 2015), Musiek reviewed recent studies implicating
circadian rhythms and neurodegeneration and emphasized
future research directions and potential therapeutic strategies for
neurodegenerative diseases.
Cardiovascular disease (CVD) is a leading cause of death
worldwide and new approaches in the management of CVD
are clearly warranted. Since cardiovascular function and the
onset of many CVDs display obvious diurnal variations, novel
pharmacologic compounds that target the circadian mechanism
may have potential clinical applications. Two review articles
in current research topic were focused on the cardiovascular
system and circadian rhythms from different views. In Recent
advances in circadian rhythms in cardiovascular system (Chen and
Yang, 2015), Chen and Yang summarized recent advances in the
understanding of the relationship between circadian rhythm and
cardiovascular physiology and diseases including blood pressure
regulation and myocardial infarction. In Therapeutic applications
of circadian rhythms for the cardiovascular system (Tsimakouridze
et al., 2015), Tsimakouridze et al. mainly focused on circadian
biomarkers, chronotherapy for CVDs and new drugs targeting
circadian clocks.
Biological clock and metabolism are tightly intertwined. On
one hand, the disturbance of circadian rhythms negatively affects
metabolic homeostasis, and thus may promote the development
of obesity and diabetes. On the other hand, high fat consumption
alters circadian behavior in mice, while temporal restriction of
food consumption limits mouse weight gain on a high fat diet
via restoring the robustness of clock gene oscillation. In mini-
review, Circadian clocks, feeding time, and metabolic homeostasis
(Paschos, 2015), Paschos collected evidence about the association
between circadian misalignment and metabolic homeostasis and
discussed the role of feeding time in energy metabolism. In
another review paper, Rodent models to study the metabolic effects
of shiftwork in humans (Opperhuizen et al., 2015), Opperhuizen
et al. provided a thorough view of animal models that are used
to mimic human shiftwork. They divided published models
in four categories, i.e., altered timing of food intake, activity,
sleep, or light exposure and scored and compared their effects
on metabolic parameters. They also discussed the drawback of
animal studies and evaluated the translatability to human beings.
Mothers who experience breastfeeding problems in the early
post-partum period are more likely to discontinue breastfeeding
within 2 weeks. A major risk factor for shorter breastfeeding
duration is delayed lactogenesis II (DLII). Based on the facts that
circadian clocks coordinate hormonal and metabolic changes
to support lactation in rodent studies, and disruption of the
circadian system intervenes the initiation of lactation and
negatively impacts milk production, Fu et al. (2015) hypothesized
that DLII is related to disruption of themother’s circadian system.
Authors reviewed literatures that support this hypothesis, and
described interventions that may help to increase breastfeeding
success.
The treatment of circadian disorders has drawn attention
recently. However, the development of pertinent drugs has a
high failure rate possibly due to the variations in chronotype.
Therefore, similar to treatment of given cancers, personalized
medicine might become a standard for drug development in the
field of chronobiology. In Personalized medicine for pathological
circadian dysfunctions (Skelton et al., 2015), Skelton et al.
reviewed the current clinical trials of circadian drugs and the
history of personalized medicine in oncology, and discussed how
personalized medicine can be used in future clinical trials for
circadian disorders.
As presented above, we recruited two research articles,
six review articles, and a hypothesis and theory article that
covered multiple aspects of Therapeutic Implications of Circadian
Rhythms, frommodel organisms to human, from central nervous
system to peripheral tissues, and from clinical study to drug
development. Although much attention has been paid to this
field in recent years, we are still far from our goal, especially the
translation of basic science into clinical applications. Therefore,
we encourage researchers to continue contributing to our
understanding of the clinical relevance of circadian systems.
Finally, we would like to thank all authors who contributed
papers to our research topic. We would also like to thank all
reviewers and editorial board for helping us to underscore the
importance and organization of this Research Topic.
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